Brokers expect Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get a rating) to report earnings per share (EPS) of $0.37 for the current quarter, according to Zacks Investment Research. Five analysts provided earnings estimates for Sabra Health Care REIT. The lowest EPS estimate is $0.36 and the highest is $0.40. Sabra Health Care REIT reported earnings of $0.39 per share in the same quarter last year, indicating a negative 5.1% year-over-year growth rate. The company is expected to announce its next results on Monday, January 1.
On average, analysts expect Sabra Health Care REIT to report annual earnings of $1.54 per share for the current fiscal year, with EPS estimates ranging from $1.50 to $1.62. For the next fiscal year, analysts expect the company to post earnings of $1.57 per share, with EPS estimates ranging from $1.51 to $1.66. Zacks’ earnings per share calculations are an average based on a survey of analysts who track Sabra Health Care REIT.
Sabra Health Care REIT (NASDAQ: SBRA – Get a rating) last reported quarterly earnings data on Wednesday, May 4. The real estate investment trust reported earnings per share (EPS) of $0.18 for the quarter, beating analysts’ consensus estimate of $0.17 by $0.01. Sabra Health Care REIT posted a negative return on equity of 3.15% and a negative net margin of 18.28%. In the same quarter a year earlier, the company posted EPS of $0.39.
SBRA has been the subject of several analyst reports. KeyCorp launched coverage on Sabra Health Care REIT in a report on Friday, February 18. They set a “sector weight” rating on the stock. Bank of America upgraded Sabra Health Care REIT from an “underperforming” rating to a “neutral” rating and set a target price of $15.00 for the company in a Friday, March 11 research report. Zacks Investment Research upgraded Sabra Health Care REIT from a “sell” rating to a “hold” rating in a research report on Saturday, February 5. JMP Securities lowered its price target on Sabra Health Care REIT from $20.00 to $16.00 and set a “buy” rating for the company in a Tuesday, February 15 research report. Finally, Mizuho reduced its price target on Sabra Health Care REIT from $18.00 to $16.00 in a Thursday, January 20 research note. Six research analysts gave the stock a hold rating and five gave the company a buy rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $16.60.
A number of institutional investors and hedge funds have recently increased or reduced their stake in SBRA. Raymond James Financial Services Advisors Inc. increased its stake in Sabra Health Care REIT by 2.8% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 26,630 shares of the real estate investment trust worth $392,000 after purchasing an additional 726 shares in the last quarter. Voya Investment Management LLC increased its holdings of Sabra Health Care REIT shares by 0.4% in the third quarter. Voya Investment Management LLC now owns 187,382 shares of the real estate investment trust worth $2,758,000 after acquiring an additional 734 shares during the period. US Bancorp DE increased its position in Sabra Health Care REIT by 17.7% during the third quarter. US Bancorp DE now owns 5,533 shares of the real estate investment trust worth $81,000 after buying an additional 831 shares last quarter. The Alaska State Department of Revenue raised its position in Sabra Health Care REIT by 0.6% during the fourth quarter. The Alaska State Department of Revenue now owns 149,160 shares of the real estate investment trust worth $2,019,000 after buying 897 additional shares in the last quarter. Finally, Cetera Investment Advisers increased its position in Sabra Health Care REIT by 1.2% during the first quarter. Cetera Investment Advisers now owns 80,608 shares of the real estate investment trust worth $1,200,000 after purchasing an additional 919 shares last quarter. 91.61% of the shares are held by institutional investors and hedge funds.
SBRA traded down $0.21 during Friday trading hours, hitting $12.78. The company’s shares had a trading volume of 2,492,108 shares, compared to its average volume of 2,697,530. The company has a debt ratio of 0.70, a quick ratio of 3.60 and a current 3.60. The company’s 50-day moving average is $13.39 and its 200-day moving average is $13.55. Sabra Health Care REIT has a 52-week low of $11.44 and a 52-week high of $19.01. The company has a market capitalization of $2.95 billion, a PE ratio of -26.08 and a beta of 1.43.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 31. Shareholders of record on Monday, May 16 will receive a dividend of $0.30. This represents a dividend of $1.20 on an annualized basis and a dividend yield of 9.39%. The ex-dividend date is Friday, May 13. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently -244.89%.
About Sabra Health Care REIT (Get a rating)
As of September 30, 2020, Sabra’s investment portfolio comprised 425 properties held for investment (including (i) 287 skilled nursing/transitional care facilities, (ii) 64 Senior Housing – Leased), (iii) 47 Senior Residences operated by third-party property managers under property management contracts (Senior Housing – Managed) and (iv) 27 Specialized Hospitals and Other Establishments), an asset held for sale , one investment in direct leasing, 19 investments in loans receivable (including (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six investments in preferred shares and one investment in an unconsolidated joint venture that owns 158 seniors housing – managed communities.
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Sabra Health Care REIT right now?
Before you consider Sabra Health Care REIT, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market goes higher…and Sabra Health Care REIT was not on the list.
Although Sabra Health Care REIT currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here